ATE404197T1 - Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem- mittel - Google Patents
Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem- mittelInfo
- Publication number
- ATE404197T1 ATE404197T1 AT02795443T AT02795443T ATE404197T1 AT E404197 T1 ATE404197 T1 AT E404197T1 AT 02795443 T AT02795443 T AT 02795443T AT 02795443 T AT02795443 T AT 02795443T AT E404197 T1 ATE404197 T1 AT E404197T1
- Authority
- AT
- Austria
- Prior art keywords
- gemifloxacin
- bacterial infections
- salts
- antibacterial agent
- treating bacterial
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 2
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title abstract 2
- ZRCVYEYHRGVLOC-HYARGMPZSA-N gemifloxacin Chemical compound C1C(CN)C(=N/OC)/CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1CC1 ZRCVYEYHRGVLOC-HYARGMPZSA-N 0.000 title abstract 2
- 229960003170 gemifloxacin Drugs 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33513101P | 2001-11-30 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404197T1 true ATE404197T1 (de) | 2008-08-15 |
Family
ID=23310394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02795443T ATE404197T1 (de) | 2001-11-30 | 2002-11-29 | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem- mittel |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050020567A1 (de) |
| EP (1) | EP1458390B1 (de) |
| AT (1) | ATE404197T1 (de) |
| AU (1) | AU2002360216A1 (de) |
| CA (1) | CA2468033C (de) |
| CY (1) | CY1108472T1 (de) |
| DE (1) | DE60228324D1 (de) |
| DK (1) | DK1458390T3 (de) |
| ES (1) | ES2312654T3 (de) |
| MX (1) | MXPA04005178A (de) |
| NO (1) | NO331599B1 (de) |
| PT (1) | PT1458390E (de) |
| WO (1) | WO2003045389A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006040893A1 (ja) * | 2004-10-08 | 2006-04-20 | Dainippon Sumitomo Pharma Co., Ltd. | 新規な抗菌性医薬 |
| US9292565B2 (en) * | 2010-06-30 | 2016-03-22 | International Business Machines Corporation | Template-based recognition of food product information |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080757A (en) * | 1996-06-06 | 2000-06-27 | Pfizer Inc | Antibiotic quinolones and derivatives |
| WO2001095876A1 (en) * | 2000-06-09 | 2001-12-20 | Baylor College Of Medicine | The combination of antimicrobial agents and bacterial interference to coat medical devices |
-
2002
- 2002-11-29 CA CA002468033A patent/CA2468033C/en not_active Expired - Fee Related
- 2002-11-29 US US10/496,803 patent/US20050020567A1/en not_active Abandoned
- 2002-11-29 AU AU2002360216A patent/AU2002360216A1/en not_active Abandoned
- 2002-11-29 EP EP02795443A patent/EP1458390B1/de not_active Expired - Lifetime
- 2002-11-29 DK DK02795443T patent/DK1458390T3/da active
- 2002-11-29 ES ES02795443T patent/ES2312654T3/es not_active Expired - Lifetime
- 2002-11-29 PT PT02795443T patent/PT1458390E/pt unknown
- 2002-11-29 DE DE60228324T patent/DE60228324D1/de not_active Expired - Lifetime
- 2002-11-29 WO PCT/KR2002/002247 patent/WO2003045389A1/en not_active Ceased
- 2002-11-29 AT AT02795443T patent/ATE404197T1/de active
- 2002-11-29 MX MXPA04005178A patent/MXPA04005178A/es active IP Right Grant
-
2004
- 2004-06-24 NO NO20042660A patent/NO331599B1/no not_active IP Right Cessation
-
2008
- 2008-10-31 CY CY20081101239T patent/CY1108472T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1458390A1 (de) | 2004-09-22 |
| CA2468033A1 (en) | 2003-06-05 |
| NO331599B1 (no) | 2012-02-06 |
| AU2002360216A1 (en) | 2003-06-10 |
| EP1458390A4 (de) | 2007-07-04 |
| PT1458390E (pt) | 2008-10-02 |
| EP1458390B1 (de) | 2008-08-13 |
| DE60228324D1 (de) | 2008-09-25 |
| ES2312654T3 (es) | 2009-03-01 |
| US20050020567A1 (en) | 2005-01-27 |
| MXPA04005178A (es) | 2004-08-11 |
| WO2003045389A1 (en) | 2003-06-05 |
| DK1458390T3 (da) | 2008-12-15 |
| CY1108472T1 (el) | 2014-04-09 |
| CA2468033C (en) | 2008-02-12 |
| NO20042660L (no) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT759774E (pt) | Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico | |
| DE60326273D1 (de) | Verfahren und verbindungen zur verstärkung der fybrozyten-bildung | |
| NO20042271L (no) | Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder | |
| DE60216614D1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
| MXPA02001254A (es) | Formulacion de moxifloxacino con sal-comun. | |
| ATE247973T1 (de) | Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen | |
| ATE534372T1 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen | |
| DE60126829D1 (de) | Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis | |
| DE60310400D1 (de) | Botulinustoxine zur behandlung von priapismus | |
| EP1694342A4 (de) | Verfahren zur verwendung von gelsolin zur behandlung oder prävention von bakterieller sepsis | |
| DE60219658D1 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
| WO2005039494A3 (en) | Inhibitors of rnase p proteins as antibacterial compounds | |
| BRPI0417421A (pt) | composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado | |
| ATE372119T1 (de) | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum | |
| ATE528004T1 (de) | Chinolon-antibiotika zur behandlung von periodontaler infektionen | |
| DE60131085D1 (de) | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika | |
| DE60228324D1 (de) | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel | |
| DE60137459D1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
| DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| ATE308895T1 (de) | Behandlung von infektionen in tieren | |
| EP1482958A4 (de) | Verfahren zur behandlung, prävention oder hemmung von enterotoxigenen infektionen mit escherichia coli mit rindererythrozyten-präparaten | |
| DE60233353D1 (de) | Verfahren zur behandlung von halitose | |
| WO2005053613A3 (en) | Combinations for the treatment of fungal infections | |
| TW200708309A (en) | Antibacterial treatment and composition | |
| RU2002112484A (ru) | Способ лечения бактериальных болезней рыб |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1458390 Country of ref document: EP |